TOPP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. TOPP is trading below its pivot (0.862) after a -5.13% regular-session drop, with no Intellectia buy signals, no supportive options-sentiment read, and pattern-based odds skewing to further near-term downside. For an impatient buyer, the current setup does not offer a strong, immediate edge.
Price/levels: Post-market ~0.8064, below Pivot 0.862. Nearest support is S1 0.755 (then S2 0.689); nearest resistance is R1 0.969 (then R2 1.035). The stock is currently closer to support than resistance, implying downside risk if 0.755 fails. Momentum: MACD histogram is positive (0.00999) but "positively contracting," which often signals bullish momentum is fading rather than strengthening. RSI(6) at ~39.5 is weak/near the lower-neutral area (not a clean oversold reversal signal). Trend: Converging moving averages suggests indecision/transition, not a confirmed uptrend. Quant/pattern outlook: Similar-candlestick analog suggests ~70% chance of -3.35% next day, ~flat next week (-0.05%), and -3.73% next month—net bearish skew.
Intellectia Proprietary Trading Signals: Intellectia Proprietary Trading Signals
Upcoming earnings (2026-02-13 pre-market) can act as a volatility/catalyst window.
Latest reported quarter showed strong YoY revenue growth (+20.29%) and materially improved gross margin (30.5, up sharply YoY), which can support a narrative of operational improvement.
Net loss improved significantly YoY (still negative, but less severe than prior year per provided YoY change).
Pattern-based forward returns show a bearish skew (notably next-day and next-month).
Latest quarter: 2025/Q3. Revenue rose to 4,494,932 (+20.29% YoY), indicating top-line growth. Gross margin improved to 30.5 (large YoY improvement), suggesting better unit economics/operational efficiency. However, net income is still negative (-4,146,657) and EPS is still negative (-0.23), so the company remains unprofitable despite YoY improvement in losses.
No analyst rating or price target data was provided, implying limited/none visible Wall Street coverage in this dataset. Pros (what analysts would likely like): accelerating revenue and improved margins. Cons: continuing net losses, micro-cap profile, and weak near-term technicals with no clear momentum trigger.
